ClinConnect ClinConnect Logo
Search / Trial NCT05775484

Exercise to Slow Cardiovascular Ageing Progression

Launched by NATIONAL HEART CENTRE SINGAPORE · Mar 7, 2023

Trial Information

Current as of June 16, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Exercise to Slow Cardiovascular Ageing Progression," is exploring how exercise can help improve heart health as we age. Researchers believe that changes in heart structure and function, which can lead to heart disease, are linked to certain substances in the blood that change as we get older. They think that by exercising, we might be able to positively influence these substances, slow down heart aging, and make it less likely to develop heart-related illnesses.

The trial is looking for participants who are at least 21 years old and can move around outdoors. However, it excludes individuals who are wheelchair-bound, have dementia, or are living in a nursing home. Participants should not have certain health issues like cancer, ongoing infections, or severe lung diseases. If you join the study, you can expect to engage in exercise interventions that aim to enhance your cardiovascular health. This research is currently recruiting, so it's a great opportunity for eligible individuals to contribute to important findings that could benefit heart health in older adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age \>=21 years old
  • Outdoor ambulant
  • Exclusion Criteria:
  • Wheelchair or bed-bound
  • Dementia
  • Residing in sheltered or nursing home
  • Cancer
  • Participation in ongoing clinical trials that involve interventional drugs or devices
  • Aneurysms
  • Acute infections (in the last six months)
  • Uncontrolled thyrotoxicosis
  • Neuromuscular, musculoskeletal or rheumatoid disorders that are exacerbated by exercise
  • Uncontrolled asthma or chronic lung disease
  • Restrictive lung disease

About National Heart Centre Singapore

The National Heart Centre Singapore (NHCS) is a leading institution dedicated to advancing cardiovascular care and research in Singapore and the Asia-Pacific region. As a premier clinical trial sponsor, NHCS is committed to improving heart health through innovative research and clinical excellence. The center specializes in a wide range of cardiovascular conditions, leveraging cutting-edge technology and a multidisciplinary approach to develop and evaluate new therapies. With a strong emphasis on patient-centered care, NHCS collaborates with various stakeholders to enhance clinical outcomes and contribute to the global body of cardiovascular knowledge.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials